When prostate cancer, one of the most lethal cancers, spreads in the body, it most often targets bone. Difficult to treat, such metastasis is implicated in over 70% of prostate cancer deaths. A new therapy crosses bone barriers.
Prof. Zelig Eshhar, Head of the Immunology Department at the Weizmann Institute of Science, previously developed prostate-cancer-fighting cells, dubbed T bodies, which are modified immune system cells customized to be highly effective in identifying and destroying cancer cells. However, T bodies were unable to effectively penetrate bone. The Weizmann team, which included Dr. Jehonathan Pinthus of Sheba Medical Center, Tel Hashomer, implemented a pre-treatment consisting of either low doses of radiation or a specific chemotherapy drug, followed by T body injections. The pre-treatments caused some disruption in the bone marrow, the intended target of the T bodies, which responded with a chemical distress signal that alerted the immune cells, aided them in locating the problem area and enabled them to pass through barriers into the bone marrow tissue.
Mice treated with either therapy showed a significant drop in the tumor marker PSA (an indicator of cancer levels), a reduction in the tumor load and prolonged survival. This method holds promise for treating disseminated cancers that are resistant to other forms of therapy.
Prof. Zelig Eshhar’s research is supported by the M.D. Moross Institute for Cancer Research; the Crown Endowment Fund for Immunological Research; the Estate of Irene Kuhn and Lotte Stern, UK; and the Harry and Jeanette Weinberg Fund for the Molecular Genetics of Cancer. Prof. Eshhar is the incumbent of the Marshall and Renette Ezralow Professorial Chair of Chemical and Cellular Immunology.
WOWing the Crowds
Instead of plates containing rows of tiny wells, the new method - developed by Drs. Dan Tawfik and Amir Aharoni of the Institute's Biological Chemistry Department and Prof. Shlomo Magdassi of the Hebrew University's Institute of Chemistry, with support from the Israel Ministry of Science and Technology - relies on microscopic droplets of water suspended inside oil droplets. The method, which uses an emulsion dubbed WOW (water-oil-water), takes a lead from living cells, which employ a fatty membrane to keep their inside and outside environments separate. Using the new system, millions of tests can be performed at once.
The method involves adding a fluorescent marker that lights up in color when activated by the right protein and sorting through the droplets for those containing the marked proteins and their coding genes. Automated devices for sorting cells can handle many thousands of droplets per second. "Searches that now take a year to complete could be done in a matter of days," says Tawfik.